Abstract #1389

MR appearance of Primary central nervous system lymphoma: as prognostic factors influencing the response to clinical treatment

jing Liu¹ and shuixing Zhang¹

¹Radiology, Department of Radiology, Guangdong Academy of Medical Sciences/Guangdong General Hospital, Guangzhou, Guangzhou, China, People's Republic of

Currently, the treatment response in primary central nervous system lymphoma (PCNSL) is monitored by serial contrast-enhanced anatomic MR imaging, which often showing characteristic radio-morphological features such as lesion location, strong and homogenous contrast-enhancement, moderate edema and absence of necrosis. The purpose of our study was to investigate the objective response rate (ORR) and identify MR findings as predictors to evaluate the therapeutic response in PCNSL. Our result shows that tumor size, number, location, homogenous enhancement and the planned therapeutic strategy were independent factors correlated with treatment response in patients of PCNSL.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.